These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11001071)

  • 1. The clinical role of long-acting beta2-agonists in COPD.
    Kips J
    Respir Med; 2000 Sep; 94 Suppl E():S1-5. PubMed ID: 11001071
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to inhaled bronchodilators in COPD.
    Anthonisen NR; Wright EC
    Chest; 1987 May; 91(5 Suppl):36S-39S. PubMed ID: 2882959
    [No Abstract]   [Full Text] [Related]  

  • 3. Bronchodilator therapy of COPD. A reanalysis suggests new roles and new concerns.
    Deffebach ME
    Chest; 1996 Jul; 110(1):5-6. PubMed ID: 8681663
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF
    Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
    Mroz RM; Minarowski L; Chyczewska E
    Adv Exp Med Biol; 2013; 756():23-8. PubMed ID: 22836615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
    Georgopoulos D; Wong D; Anthonisen NR
    Chest; 1990 Feb; 97(2):280-4. PubMed ID: 1967572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of theophylline associated with short-acting or long-acting inhaled beta2-agonists in patients with stable chronic obstructive pulmonary disease: a systematic review.
    Zacarias EC; Castro AA; Cendon S
    J Bras Pneumol; 2007; 33(2):152-60. PubMed ID: 17724534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution computed tomography (HRCT) assessment of beta 2-agonist induced bronchodilation in chronic obstructive pulmonary disease patients.
    De Luca N; Capuzi P; D'Angeli AL; D'Antoni L; Pavone P; De Santis M; Di Girolamo M; Catalano C; Passariello R
    Eur Rev Med Pharmacol Sci; 1999; 3(2):83-7. PubMed ID: 10827809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
    Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW
    Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination bronchodilator therapy in COPD.
    Rennard SI
    Chest; 1995 May; 107(5 Suppl):171S-175S. PubMed ID: 7743822
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
    Johnson M; Rennard S
    Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic obstructive pulmonary disease: an evidence-based approach to treatment with a focus on anticholinergic bronchodilation.
    Gross NJ
    Mayo Clin Proc; 2008 Nov; 83(11):1241-50. PubMed ID: 18990323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF; Matera MG
    Thorax; 1999 Aug; 54(8):730-6. PubMed ID: 10413727
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.
    Chapman KR; Wanner A
    Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of inhaled beta2-agonists on clinical outcomes in chronic obstructive pulmonary disease.
    Mahler DA
    J Allergy Clin Immunol; 2002 Dec; 110(6 Suppl):S298-303. PubMed ID: 12464939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.